Stemtech Corp (STEK) Cost of Revenue (2021 - 2026)

Stemtech has reported Cost of Revenue for 6 years, with the latest figure at $99900.0 in Q1 2026.

• Quarterly Cost of Revenue fell 32.4% year-over-year to $99900.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $536753.0 (down 74.17% YoY) and the FY2025 annual result came in at $566940.0, down 57.26% from the prior year.
• Cost of Revenue fell to $99900.0 in Q1 2026 per STEK's latest filing, from $148277.0 in the prior quarter.
• Over five years, Cost of Revenue peaked at $1.2 million in Q4 2024 and troughed at -$449578.0 in Q4 2023.
• A 5-year average of $250657.8 and a median of $231817.0 in 2023 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue sank 237.23% in 2023, then soared 375.83% in 2024.
• Over 5 years, Cost of Revenue stood at $327609.0 in 2022, then tumbled by 237.23% to -$449578.0 in 2023, then soared by 375.83% to $1.2 million in 2024, then tumbled by 88.04% to $148277.0 in 2025, then tumbled by 32.63% to $99900.0 in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $99900.0, $148277.0, and $161756.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.